NYSE:FMS - Fresenius Medical Care AG & Co. Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$39.37 -0.70 (-1.75 %)
(As of 04/19/2019 01:12 PM ET)
Previous Close$40.07
Today's Range$39.30 - $39.67
52-Week Range$30.99 - $53.40
Volume338,955 shs
Average Volume239,925 shs
Market Capitalization$24.16 billion
P/E Ratio17.34
Dividend Yield1.07%
Beta1.4
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist, emergency, intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2018, it operated 3,928 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Receive FMS News and Ratings via Email

Sign-up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone49-6172-608-2522

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$19.44 billion
Cash Flow$3.4748 per share
Book Value$24.83 per share

Profitability

Net Income$2.34 billion

Miscellaneous

Employees112,658
Market Cap$24.16 billion
Next Earnings Date5/2/2019 (Confirmed)
OptionableOptionable

Fresenius Medical Care AG & Co. (NYSE:FMS) Frequently Asked Questions

What is Fresenius Medical Care AG & Co.'s stock symbol?

Fresenius Medical Care AG & Co. trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

How often does Fresenius Medical Care AG & Co. pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co. announced an annual dividend on Thursday, May 10th. Investors of record on Tuesday, May 22nd will be paid a dividend of $0.436 per share on Monday, June 4th. This represents a yield of 0.86%. The ex-dividend date is Monday, May 21st. View Fresenius Medical Care AG & Co.'s Dividend History.

How were Fresenius Medical Care AG & Co.'s earnings last quarter?

Fresenius Medical Care AG & Co. (NYSE:FMS) posted its quarterly earnings results on Wednesday, February, 20th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.64 by $0.02. The firm had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $5.01 billion. Fresenius Medical Care AG & Co. had a return on equity of 10.14% and a net margin of 12.00%. View Fresenius Medical Care AG & Co.'s Earnings History.

When is Fresenius Medical Care AG & Co.'s next earnings date?

Fresenius Medical Care AG & Co. is scheduled to release their next quarterly earnings announcement on Thursday, May 2nd 2019. View Earnings Estimates for Fresenius Medical Care AG & Co..

What guidance has Fresenius Medical Care AG & Co. issued on next quarter's earnings?

Fresenius Medical Care AG & Co. issued an update on its FY 2019 earnings guidance on Wednesday, February, 20th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $18.818-19.549 billion, compared to the consensus revenue estimate of $19.91 billion.

What price target have analysts set for FMS?

9 Wall Street analysts have issued 1-year price targets for Fresenius Medical Care AG & Co.'s shares. Their forecasts range from $48.00 to $82.00. On average, they anticipate Fresenius Medical Care AG & Co.'s share price to reach $65.00 in the next year. This suggests a possible upside of 65.1% from the stock's current price. View Analyst Price Targets for Fresenius Medical Care AG & Co..

What is the consensus analysts' recommendation for Fresenius Medical Care AG & Co.?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. in the last year. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Fresenius Medical Care AG & Co..

Has Fresenius Medical Care AG & Co. been receiving favorable news coverage?

News stories about FMS stock have trended very positive on Friday, according to InfoTrie Sentiment. The research firm ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Fresenius Medical Care AG & Co. earned a media sentiment score of 3.6 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next few days.

Who are some of Fresenius Medical Care AG & Co.'s key competitors?

What other stocks do shareholders of Fresenius Medical Care AG & Co. own?

Who are Fresenius Medical Care AG & Co.'s key executives?

Fresenius Medical Care AG & Co.'s management team includes the folowing people:
  • Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 64)
  • Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 64)
  • Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 60)
  • Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 47)
  • Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 57)

Who are Fresenius Medical Care AG & Co.'s major shareholders?

Fresenius Medical Care AG & Co.'s stock is owned by a variety of of institutional and retail investors. Top institutional investors include Confluence Investment Management LLC (0.00%), Hartwell J M Limited Partnership (0.00%), FNY Investment Advisers LLC (0.00%), Eqis Capital Management Inc. (0.00%), We Are One Seven LLC (0.00%) and Fulton Bank N.A. (0.00%).

Which major investors are selling Fresenius Medical Care AG & Co. stock?

FMS stock was sold by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC, Confluence Investment Management LLC and Fulton Bank N.A..

Which major investors are buying Fresenius Medical Care AG & Co. stock?

FMS stock was bought by a variety of institutional investors in the last quarter, including We Are One Seven LLC, Eqis Capital Management Inc. and Hartwell J M Limited Partnership.

How do I buy shares of Fresenius Medical Care AG & Co.?

Shares of FMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fresenius Medical Care AG & Co.'s stock price today?

One share of FMS stock can currently be purchased for approximately $39.37.

How big of a company is Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co. has a market capitalization of $24.16 billion and generates $19.44 billion in revenue each year. The company earns $2.34 billion in net income (profit) each year or $2.27 on an earnings per share basis. Fresenius Medical Care AG & Co. employs 112,658 workers across the globe.

What is Fresenius Medical Care AG & Co.'s official website?

The official website for Fresenius Medical Care AG & Co. is http://www.freseniusmedicalcare.com.

How can I contact Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co.'s mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The company can be reached via phone at 49-6172-608-2522 or via email at [email protected]


MarketBeat Community Rating for Fresenius Medical Care AG & Co. (NYSE FMS)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  283 (Vote Outperform)
Underperform Votes:  430 (Vote Underperform)
Total Votes:  713
MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care AG & Co. and other stocks. Vote "Outperform" if you believe FMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel